# Animal Drugs, Feeds, and Related Products; Cephapirin Sodium for Intramammary Infusion; Redesignation
> **Food and Drug Administration** · Final rule. · Published 1998-02-19 · Effective 1998-02-19 · 63 FR 8349
## Document
- **Document number:** 98-4081
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 63 FR 8349
- **CFR reference:** 21 CFR 526
- **Publication date:** 1998-02-19
- **Effective date:** 1998-02-19
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to redesignate a section of those regulations. A section reflecting approval of an intramammary product is redesignated from certain other dosage form new animal drugs to intramammary dosage forms to reflect the correct designation of the product.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1998/02/19/98-4081/animal-drugs-feeds-and-related-products-cephapirin-sodium-for-intramammary-infusion-redesignation)
---
*AI Analytics · CC0 1.0*